Try for free

Wild Indigo

Wild Indigo

OTHER NAME(S): American Indigo, Añil Silvestre, Baptisia Root, Baptista, False Indigo, Faux Indigo, Horsefly Weed, Indigo Broom, Indigo Silvestre, Rattlebush, Yellow Broom, Yellow Indigo, Baptisia tinctoria, Índigo Silvestre, Indigo Sauvage

Overview

Wild indigo is an herb. The root is used to make medicine. Sometimes the sap of wild indigo is used as a dye.

Wild indigo is used for infections such as diphtheria, influenza (flu), the common cold, other upper respiratory tract infections, malaria, typhoid, and many other conditions, but there is no good scientific evidence to support these uses.

Do not confuse wild indigo with other plants that are often referred to as indigo. Also, don't confuse wild indigo with indigo carmine. Indigo carmine is a dye that is created in a lab and is used for many industrial purposes.

There isn't enough information to know how wild indigo works.

There isn't enough information to know how wild indigo works.

References
  1. McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.
  2. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
  3. Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.
  4. Beuscher N, Scheit KH, Bodinet C, Kopanski L. [Immunologically active glycoproteins of Baptisia tinctoria]. Planta Med 1989;55:358-63.
  5. Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract 1999;48:628-35.
  6. Henneicke-von Zepelin H, Hentschel C, Schnitker J, et al. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo-controlled, multicentre study. Curr Med Res Opin 1999;15:214-27.
  7. Bockhorst H, Gollnick N, Guran S, et al. [Therapy of herpes simplex in practice. Report on the treatment of herpes simplex labialis with Esberitox]. ZFA.(Stuttgart.) 11-20-1982;58:1795-98.
  8. Bendel R, Bendel V, Renner K, et al. [Additional treatment with Esberitox N in patients with chemo- radiotherapy treatment of advanced breast cancer]. Onkologie. 1989;12 Suppl 3:32-8.
  9. Bendel R, Bendel V, Renner K, et al. [Supplementary treatment with Esberitox of female patients undergoing curative adjuvant irradiation following breast cancer]. Strahlenther.Onkol. 1988;164:278-83.
  10. Egert, D. and Beuscher, N. Studies on antigen specifity of immunoreactive arabinogalactan proteins extracted from Baptisia tinctoria and Echinacea purpurea. Planta Med. 1992;58(2):163-165.
  11. Wack, M., Classen, B., and Blaschek, W. An acidic arabinogalactan-protein from the roots of Baptisia tinctoria. Planta Med. 2005;71(9):814-818.
  12. Wagner, H. and Jurcic, K. [Immunologic studies of plant combination preparations. In-vitro and in-vivo studies on the stimulation of phagocytosis]. Arzneimittelforschung. 1991;41(10):1072-1076.
  13. Hauke, W., Kohler, G., Henneicke-von Zepelin, H. H., and Freudenstein, J. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study. Chemotherapy 2002;48(5):259-266.
  14. Naser, B., Lund, B., Henneicke-von Zepelin, H. H., Kohler, G., Lehmacher, W., and Scaglione, F. A randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common cold. Phytomedicine. 2005;12(10):715-722.
  15. Wustenberg, P., Henneicke-von Zepelin, H. H., Kohler, G., and Stammwitz, U. Efficacy and mode of action of an immunomodulator herbal preparation containing Echinacea, wild indigo, and white cedar. Adv.Ther 1999;16(1):51-70.
  16. Bodinet, C. and Freudenstein, J. Effects of an orally applied aqueous-ethanolic extract of a mixture of Thujae occidentalis herba, Baptisiae tinctoriae radix, Echinaceae purpureae radix and Echinaceae pallidae radix on antibody response against sheep red blood cells in mice. Planta Med 1999;65(8):695-699.
  17. Kohler, G., Bodinet, C., and Freudenstein, J. [Pharmacodynamic effects and clinical effectiveness of a combination of herbal substances comprised of Cone Flower, Wild Indigo and White Cedar]. Wien.Med Wochenschr. 2002;152(15-16):393-397.
  18. Bodinet, C., Lindequist, U., Teuscher, E., and Freudenstein, J. Effect of an orally applied herbal immunomodulator on cytokine induction and antibody response in normal and immunosuppressed mice. Phytomedicine. 2002;9(7):606-613.
  19. Bostelmann, H. C., Bodeker, R. H., Dames, W., Henneicke-von Zepelin, H. H., Siegers, C. P., and Stammwitz, U. [Immunomodulation by herbal agents. A double-blind study in a medical university hospital involving a hepatitis B vaccine adjuvant model]. Fortschr.Med Orig. 12-5-2002;120(4):119-123.
  20. HOFFMANN, R. [Esberitox, an oral remedy for non-specific therapeutic irritation in infectious inflammation]. Ther Ggw. 1952;91(5):186.
  21. SCHWARZ, F. K. [Peroral change of general reaction to infections by esberitox]. Med Klin.(Munich) 10-3-1952;47(40):1320-1322.
  22. VON OETTINGEN, E. N. [Acute diseases of the ear and neck; contribution to the use of esberitox]. Ther Ggw. 1954;93(4):152-153.
  23. JOHNE, H. O. and SPERR, A. [Experimental and clinical experiences with stimulation therapy with gluco-lipopolypeptide complexes (esberitox) in dermatology]. Medizinische. 8-25-1956;7(33-34):1145-1147.
  24. HELBIG, G. [Nonspecific therapy with irritants for infection prophylaxis. A study of the therapeutic effect of Esberitox]. Med Klin. 9-1-1961;56:1512-1514.
  25. Bodinet, C., Lindequist, U., Teuscher, E., and Freudenstein, J. Influence of peroral application of a herbal immunomodulator on the antibody production of Peyer's patches cells. Arzneimittelforschung. 2004;54(2):114-118.
  26. Classen, B., Csavas, M., Borbas, A., Dingermann, T., and Zundorf, I. Monoclonal Antibodies against an Arabinogalactan-Protein from Pressed Juice of Echinacea purpurea. Planta Med. 2004;70(9):861-865.
  27. Guo, R., Pittler, M. H., and Ernst, E. Herbal medicines for the treatment of COPD: a systematic review. Eur.Respir.J 2006;28(2):330-338.
  28. Classen, B., Thude, S., Blaschek, W., Wack, M., and Bodinet, C. Immunomodulatory effects of arabinogalactan-proteins from Baptisia and Echinacea. Phytomedicine. 2006;13(9-10):688-694.
  29. Roxas, M. and Jurenka, J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern.Med Rev. 2007;12(1):25-48.
  30. Vomel, T. [Effect of a plant immunostimulant on phagocytosis of erythrocytes by the reticulohistiocytary system of isolated perfused rat liver]. Arzneimittelforschung. 1985;35(9):1437-1439.
  31. Sartor, K. J. [Efficacy of Esberitox in the treatment of radiation-induced leukopenia]. Ther Ggw. 1972;111(8):1147-1150.
  32. Kleinschmidt, H. [An experiment to decrease susceptibility to infections in young children with Esberitox]. Ther Ggw. 1965;104(9):1258-1262.
  33. Gerhardt, P. [Influence of an unspecific stimulation therapy using Esberitox on leukopoiesis during the use of ionizing radiation]. Strahlentherapie. 1972;143(5):549-558.
  34. Pohl, P. [Treatment of radiation-induced leukopenia with Esberitox]. Ther Ggw. 1970;109(6):902-906.
  35. Beuscher, N., Beuscher, H., Otto, B., and Schafer, B. [Modification by drugs of cellular and humoral resistance mechanisms in animal experiments. I. In-vitro studies of peritoneal leukocytes and serums in rats]. Arzneimittelforschung. 1977;27(9):1655-1660.
  36. Beuscher, N. [On the influence of drugs on cellular mechanism of resistance in the animal experiment. III. Enhancement of leukocyte mobilisation in the mouse by a resistance stimulant on plant base (author's transl)]. Arzneimittelforschung. 1980;30(5):821-825.
  37. Beuscher, N. [On the influence of drugs on cellular mechanisms of resistance in the animal experiment/Activation of peritoneal macrophages of the mouse by a resistance stimulant on plant base (author's transl)]. Arzneimittelforschung. 1982;32(2):134-138.
  38. Forth, H. and Beuscher, N. Beeinflussing der Häufigkeit banaler Erkältungsinfekte durch Esberitox. Zeitschrift für Allgemeinmedizin [Effect on the frequency of banal cold infections by esberitox]. ZFA.(Stuttgart.) 11-20-1981;57(32):2272-2275.
  39. Kindzel'skii, L. P., Zlochevskaia, L. L., Tsyganok, T. V., and Shabaeva, M. M. [The effect of natural immunomodulators on the lymphocytic natural killer activity in patients with malignant lymphoproliferative diseases]. Lik.Sprava. 1995;(1-2):146-148.
  40. Wagner, H., Proksch, A., Riess-Maurer, I., Vollmar, A., Odenthal, S., Stuppner, H., Jurcic, K., Le, Turdu M., and Heur, Y. H. [Immunostimulant action of polysaccharides (heteroglycans) from higher plants. Preliminary communication]. Arzneimittelforschung. 1984;34(6):659-661.
  41. Imoto, S., Fukukita, H., Murakami, K., Ikeda, H., and Moriyama, N. Pilot study on sentinel node biopsy in breast cancer. J Surg Oncol 2000;73(3):130-133.
  42. Hentschel, C., Schnitker, J., Kohnen, R., Kohler, G., Lindhauer, I., and Henneicke-von Zepelin, H. H. [Phytotherapeutic drugs for the common cold. Results of a randomized controlled double-blind study]. MMW.Fortschr.Med. 3-2-2000;142(9):46.
  43. Ikeda, T., Jinno, H., Fujii, H., and Kitajima, M. Recent development of sentinel lymph node biopsy for breast cancer in Japan. Asian J Surg 2004;27(4):275-278.
  44. Guo, R., Canter, P. H., and Ernst, E. Herbal medicines for the treatment of rhinosinusitis: a systematic review. Otolaryngol.Head Neck Surg. 2006;135(4):496-506.
  45. Dowlatshahi, K., Jokich, P. M., Schmidt, R., Bibbo, M., and Dawson, P. J. Cytologic diagnosis of occult breast lesions using stereotaxic needle aspiration. A preliminary report. Arch Surg 1987;122(11):1343-1346.
  46. Wagner, H., Proksch, A., Riess-Maurer, I., Vollmar, A., Odenthal, S., Stuppner, H., Jurcic, K., Le Turdu, M., and Fang, J. N. [Immunostimulating action of polysaccharides (heteroglycans) from higher plants]. Arzneimittelforschung 1985;35(7):1069-1075.
  47. Beuscher, N. and Kopanski, L. [Stimulation of immunity by the contents of Baptisia tinctoria]. Planta Med 1985;(5):381-384.
  48. Pohl, P. [On the therapy of irradiation-induced leukopenia with Esberitox]. Med.Klin. 1969;64(35):1546-1547.
  49. Wagner, H., Horhammer, L., Budweg, W., Major, A., and Farkas, L. [Investigation of the glycosides from Baptisia tinctoria. 3. Synthesis of pseudobaptisins]. Chem.Ber. 1969;102(9):3006-3008.
  50. Ragosch, V., Hundertmark, S., Hopp, H., Opri, F., and Weitzel, H. K. [Insulin-like-growth-factor-binding-protein 1 (IGFBP-1) and fetal fibronectin in diagnosis of premature rupture of fetal membranes]. Geburtshilfe Frauenheilkd. 1996;56(6):291-296.
  51. Hentschel C, Zeppelin HH Kohnen R Kohler G Wustenberg P Ernst E. Clinical efficacy of Esberitox in common cold - results of a (GCP) randomised double-blind placebo-controlled multicenter study. Focus on Alternative and Complementary Ther 1997;2(4):189.
  52. Reitz HD. [Immunomodulation with phytotherapeutic agents: a scientific study on the example of Esberitox]. Notabene medici 1990;20:362-366.
  53. Zimmer M. Specific conservative treatment of acute sinusitis in the ENT practice. Therapiewoche 1985;35:4024-4028.
  54. Liesen H, Kleiter K Mucke S Order U Widenmayer W Riedel H. Leucocytes and lymphocyte subpopulations in players of the German Olympic games in 1988. Deutsch Zeitschrift fur Soprtmedizin 1989;1-10.
  55. Blunck KD. Susceptibility to infection at children's home-to increase the resistance against infections. Kinderarzt 1983;14:991-992.
  56. Stolze H and Forth H. [A treatment with antibiotics can be optimized by additional immunostimulation]. Der Kassenartz 1983;23:43-48.
  57. Vorberg G. For colds, stimulate the nonspecific immune system. Arztliche Praxis 1984;6:97-98.
  58. von Blumroeder W-O. [Angina lacunaris. An investigation on how to stimulate the endogenous defense system] (German). Z.Allg.Med. 1985;61:271-273.